1. Lokich J, Anderson N. Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agents. Ann Oncol. 1997;8:15–25.
2. Aisner J, Van Echo DA, Whitacre M, Wiernik PH. A phase I trial of continuous infusion VP16-213 (etoposide). Cancer Chemother Pharmacol. 1982;7:157–160.
3. Frei ED, Bickers JN, Hewlett JS, et al. Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). Cancer Res. 1969;29:1325–1332.
4. Wiernik PH, Schwartz EL, Strauman JJ, et al. Phase I clinical and pharmacokinetic study of taxol. Cancer Res. 1987;47:2486–2493.
5. O Dwyer PJ, Hudes GR, Walczak J, et al. Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule. Cancer Res. 1992;52:6746–6753.